Skip to content

Transluminal drainage of pancreatic fluid collections using a self-expandable metallic stent.

Transluminal drainage of pancreatic fluid collections using a self-expandable metallic stent -PATENT trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23102
Enrollment
25
Registered
2013-01-14
Start date
2013-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis systematic pancreatic fluid collection endoscopic transmural drainage self-expandable metal stent

Interventions

Endoscopic transmural drainage of pancreatic fluid collecting with placement of self-expandable metal stent.

Sponsors

University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient over 17 years; 2. Symptomatic pancreatic fluid collection that requires endoscopic drainage.

Exclusion criteria

Exclusion criteria: 1. Infected pancreatic necrosis; 2. Recurrence of prior treated pancreatic fluid collection; 3. Not fulfilling standard criteria to undergo PFC drainage according to local guidelines; 4. ASA class IV or V.

Design outcomes

Primary

MeasureTime frame
The primary endpoints are safety and efficacy: 1. Safety is expressed as the number of SAEs that are related to the procedure; 2. Efficacy is expressed as the number of PFC resolutions at 3 months after drainage. The intervention is considered safe when the maximum rate of SAE’s (related to the treatment) is 5%. The procedure is regarded effective if at least 85% of PFC have been resolved at 3 months. PFC resolution is defined as a PFC < 3 cm.

Secondary

MeasureTime frame
1. ‘Ease of use’ measured as the scope-in and scope-out time interval during the procedure in which the SEMS is placed; 2. Removability of covered self-expendable metallic stent after PFC resolution. Removability and ease of use will be graded on a visual analogue scale of 0-10: 0 being not able to remove the SEMS and 10 very easy removal of the SEMS.

Contacts

Public ContactTessa Verlaan

Dept. of Gastroenterology and Hepatology/ Dept. of Surgery Academic Medical Center Amsterdam Meibergdreef 9

T.Verlaan@amc.uva.nl+31 (0)20 5665584

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)